Lysophosphatidic acid activates peroxisome proliferator activated receptor-γ in CHO cells that over-express glycerol 3-phosphate acyltransferase-1

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Stapleton, Cliona M ^a   Mashek, Douglas G ^a,e   Wang, Shuli ^a   Nagle, Cynthia A ^a   Cline, Gary W ^b   Thuillier, Philippe ^c   Leesnitzer, Lisa M ^d   Li, Lei O ^a   Stimmel, Julie B ^d   Shulman, Gerald I ^b   Coleman, Rosalind A ^a  

^a IL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d GLAXOSMITHKLINE   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 2; CD36 ANTIGEN; DIACYLGLYCEROL KINASE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDIC ACID; POLYUNSATURATED FATTY ACID; ROSIGLITAZONE; TROGLITAZONE; UNCLASSIFIED DRUG; LYSOPHOSPHOLIPID;

ANIMAL CELL; ARTICLE; CELL LEVEL; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; INTRACELLULAR SIGNALING; LIPOGENESIS; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; TRANSACTIVATION; WILD TYPE; ANIMAL; CRICETULUS; DRUG POTENTIATION; GENETICS; HAMSTER; MASS SPECTROMETRY; METABOLISM; PLASMID; TRANSCRIPTION INITIATION;

CRICETULUS GRISEUS;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; GLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; LYSOPHOSPHOLIPIDS; MASS SPECTROMETRY; PLASMIDS; PPAR GAMMA; TRANSCRIPTIONAL ACTIVATION;

EID: 79955434677     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018932     Document Type: Article

References (34)

1. Gervois P, Fruchart J-C, Staels B, (2004) Inflammation, dyslipidaemia, diabetes and PPARs: pharmacological interest of dual PPARa and PPARg agonists. Int J Clin Pract 58: 22-29.
2. Berger J, Moller DE, (2002) The mechanisms of action of PPARs. Annu Rev Med 53: 409-435.
3. Moolenaar WH, van Meeteren LA, Giepmans BN, (2004) The ins and outs of lysophosphatidic acid signaling. Bioessays 26: 870-881.
4. McIntyre TM, Pontsler AV, Silva AR, Hilaire A St, Xu Y, et al. (2003) Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPAR agonist. Proc Natl Acad Sci USA 100: 131-136.
5. Tsukahara T, Tsukahara R, Yasuda S, Makarova N, Valentine WJ, et al. (2006) Different residues mediate recognition of 1-O-oleyl-lysophosphatidic acid and rosiglitazone in the ligand binding domain of PPARg. J Biol Chem 281: 3398-3407.
6. Zhang C, Baker DL, Yasuda S, Makarova N, Balazs L, et al. (2004) Lysophosphatidic acid induces neointima formation through PPARgamma activation. J Exp Med 199: 763-774.
7. Tigyi G, Parrill AL, (2003) Molecular mechanisms of lysophosphatidic acid action. Prog Lipid Res 42: 498-526.
8. Aoki J, (2004) Mechanisms of lysophosphatidic acid production. Semin Cell Devel Biol 15: 477-489.
9. Coleman RA, Lee DP, (2004) Enzymes of triacylglycerol synthesis and their regulation. Prog Lipid Res 43: 134-176.
10. Hammond LE, Neschen S, Romanelli AJ, Cline GW, Ilkayeva OR, et al. (2005) Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs. J Biol Chem 280: 25629-25636.
11. Nagle CA, An J, Shiota M, Torres TP, Cline GW, et al. (2007) Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance. J Biol Chem 282: 14807-14815.
12. Igal RA, Wang S, Gonzalez-Baró M, Coleman RA, (2001) Mitochondrial glycerol phosphate acyltransferase directs incorporation of exogenous fatty acids into triacylglycerol. J Biol Chem 276: 42205-42212.
13. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, et al. (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors a and g. Proc Natl Acad Sci USA 94: 4318-4323.
14. Sher T, Yi HF, McBride OW, Gonzales FJ, (1993) cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32: 5598-5604.
15. Yan ZH, Karam WG, Staudinger JL, Medvedev A, Ghanayem BI, et al. (1998) Regulation of peroxisome proliferator-activated receptor alpha-induced transactivation by the nuclear orphan receptor TAK1/TR4. J Biol Chem 273: 10948-10957.
16. Haque W, Garg A, Agarwal AK, (2005) Enzymatic activity of naturally occurring 1-acylglycerol-3-phosphate-O-acyltransferase 2 mutants associated with congenital generalized lipodystrophy. Biochem Biophys Res Commun 327: 446-453.
17. Jiang Y, Qian W, Hawes JW, Walsh JP, (2000) A domain with homology to neuronal calcium sensors is required for calcium-dependent activation of diacylglycerol kinase. J Biol Chem 275: 34092-34099.
18. Mashek DG, McKenzie MA, Van Horn CG, Coleman RA, (2006) Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and partitioning to cellular triacylglycerol in McArdle-RH7777 cells. J Biol Chem 281: 945-950.
19. Deutsch J, Grange E, Rapoport SI, Purdon AD, (1994) Isolation and quantitation of long-chain acyl-coenzyme A esters in brain tissue by solid-phase extraction. Anal Biochem 220: 321-323.
20. Yu C, Chen Y, Cline GW, Zhang D, Zong H, et al. (2002) Mechanism by which fatty acids inhibit insulin activation of IRS-1 associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230-50236.
21. Nichols JS, Parks DJ, Consler TG, Blanchard SG, (1998) Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain. Anal Biochem 257: 112-119.
22. Tsukahara T, Tsukahara R, Fujiwara Y, Yue J, Cheng Y, et al. (2010) Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPARgamma by cyclic phosphatidic acid. Mol Cell 39: 421-432.
23. Wang X, Devaiah SP, Zhang W, Welti R, (2006) Signaling functions of phosphatidic acid. Prog Lipid Res 45: 250-278.
24. Holdsworth G, Slocombe P, Hutchinson G, Milligan G, (2005) Analysis of endogenous S1P and LPA receptor expression in CHO-K1 cells. Gene 350: 59-63.
25. Simon MF, Rey A, Castan-Laurel I, Grés S, Sibrac D, et al. (2002) Expression of ectolipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes: Involvement in the control of lysophosphatidic acid production. J Biol Chem 277: 23131-23136.
26. Simons K, Ehehalt R, (2002) Cholesterol, lipid rafts, and disease. J Clin Invest 110: 597-603.
27. Davis RJ, Ganong BR, Bell RM, Czech MP, (1985) sn-1,2-Dioctanoylglycerol. A cell-permeable diacylglycerol that mimics phorbol diester action on the epidermal growth factor receptor and mitogenesis. J Biol Chem 260: 1562-1566.
28. Pagano RE, Longmuir KJ, (1985) Phosphorylation, transbilayer movement, and facilitated intracellular transport of diacylglycerol are involved in the uptake of a fluorescent analog of phosphatidic acid by cultured fibroblasts. J Biol Chem 260: 1909-1916.
29. Aoki J, Taira A, Takanezawa Y, Kishi Y, Hama K, et al. (2002) Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 277: 48737-48744.
30. Anliker B, Chun J, (2004) Lysophospholipid G protein-coupled receptors. J Biol Chem 279: 20555-20558.
31. Guo W, Huang N, Cai J, Xie W, Hamilton JA, (2005) Fatty acid transport and metabolism in HepG2 cells. Am J Physiol Gastrointest Liver Physiol 290: G528-534.
32. Memon RA, Tecott LH, Nonogaki K, Beigneux AP, Moser AH, et al. (2000) Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141: 4021-4031.
33. Gimeno RE, Cao J, (2008) Thematic review series: Glycerolipids. Mammalian glycerol-3-phosphate acyltransferases: new genes for an old activity. J Lipid Res 49: 2079-2088.
34. Wendel AA, Li LO, Li Y, Cline GW, Shulman GI, et al. (2010) Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity. Diabetes 59: 1321-1329.